Aignostics
Aignostics is an artificial intelligence (AI) company that transforms complex multi-modal pathology data into actionable insights for biopharmaceutical clients. They develop best-in-class products and services for precision medicine, supporting drug discovery, translational research, and companion diagnostics (CDx) development. Their focus is on high-quality science and relentless innovation, bringing transparency and rigor to their client's work.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $34M
Date: 29-Oct-2024
Investors: ATHOS, Mayo Clinic, HTGF, Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund, VC Fonds Technologie managed by IBB Ventures
Markets: AI, Healthtech, Biotechnology, Software Development, Health Care, Health Diagnostics, Machine Learning, Software
HQ: Berlin, Berlin, Germany
Founded: 2018
Website: https://www.aignostics.com/
LinkedIn: https://www.linkedin.com/company/aignostics
Twitter: https://twitter.com/aignostics
Facebook: https://www.facebook.com/AIgnostics/
Crunchbase: https://www.crunchbase.com/organization/aignostics
Leave a Comment
Comments
No comments yet.